Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Market Cap	278.39M +270.3%
Revenue (ttm)	46.43M +22.6%
Net Income	-29.78M
EPS	-0.38
Shares Out	99.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,535
Average Volume	91,860
Open	2.830
Previous Close	2.850
Day's Range	2.800 - 2.900
52-Week Range	0.950 - 3.560
Beta	1.08
RSI	49.46
Earnings Date	Feb 20, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 29
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: BIOWKS

Financial Performance

In 2024, Bio-Works Technologies AB's revenue was 30.49 million, a decrease of -30.55% compared to the previous year's 43.90 million. Losses were -37.36 million, -34.25% less than in 2023.